Job description
The Research Scientist / Project Leader will be part of the Discovery Parasiticides team at Elanco, focusing on the early research phase of animal health. This role involves leading the identification of next-generation molecular hits against parasites, ensuring a robust pipeline for both Pet Health and Farm Animals. The position requires collaboration with multi-functional, international teams and managing complex biological datasets to guide decision-making. The ideal candidate will drive discovery programs from concept to candidate selection while fostering innovation and scientific rigor.
Requirements
- PhD in Biology, Veterinary Medicine, Parasitology, or a related scientific field.
- A minimum of 4 years of industrial R&D experience in a project leadership capacity.
- Proven track record in target identification and validation within Animal Health or Pharma.
- Demonstrated success leading complex cross-functional teams without direct authority.
Responsibilities
- Lead research activities to identify and validate novel targets using multi-omics and functional models for small/large molecules and vaccines.
- Drive discovery programs from concept to candidate selection, ensuring scientific rigor and meeting timeline milestones for next-generation parasiticides.
- Lead multi-functional, international teams to influence selection and transition candidates seamlessly into the development pipeline.
- Oversee the generation and interpretation of complex biological datasets to guide high-stakes decision-making.
- Manage a strategic network with academic institutions and contract research organizations in close collaboration with the External Innovation Team to achieve research goals.
Benefits
- Employees at Elanco are often offered competitive compensation with annual bonus and equity eligibility, retirement plans (including a U.S. 401(k)), and comprehensive health coverage—medical, dental, vision, company-paid life and disability—and even pet insurance. Time-off and flexibility typically include generous PTO, U.S. mid-year and year-end paid shutdown weeks, parental leave, and flexible/remote work options. Employees also benefit from strong development programs (onboarding, course libraries, mentorship, nine ERGs, and tiered leadership programs) that support both professional growth and community involvement.
H-1B filing history
Public USCIS petition and DOL LCA counts · latest USCIS FY2026, LCA FY2026
Combined across 2 filing entities: Elanco Us Inc, Elanco Animal Health Inc
As of Aug 23, 2026
Initial approvals
4
FY2026
Approval rate
100.0%
FY2026
LCA certified
12
FY2026
Entry-level share
0.0%
FY2026
Initial approvals YoY
+3%
Trend
LCA certified YoY
-25%
Trend
Initial approvals by fiscal year
Approval rate by fiscal year
Continuing vs initial approvals
LCA certified positions by quarter
LCA certified positions by fiscal year
Based on public USCIS and DOL filings; not a sponsorship guarantee.
Is this posting expired or inaccurate?
